Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is ...

If you are interested in combining chemistry, biology, mathematics and computer techniques with pharmacology, physiology and biochemistry, to work on the development of treatments to prevent disease ...

The University of Iowa put in a request for a new undergraduate program for pharmacy sciences to the Iowa Board of Regents ...

A paradigm shift is under way in pharmaceutical sciences, and we are poised to lead the way. With a proud tradition of innovation stretching back 130 years, our robust research enterprise continues, ...

Reflecting on his 30-year career in the pharmaceutical industry, Jerry St. Peter ’89 sees a direct connection between his UMass Lowell experience and his success. “When I look back on my time at the ...

Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and sourcing strategies (6,7).

As tariffs have impacted the supply chain, LabViva CEO Siamak Baharloo says his company is helping life sciences and ...

The study investigates partitioning, adsorption, and electrostatic interactions in HILIC, focusing on nucleoside retention ...

Pharmaceutical Sciences encompass a broad spectrum of disciplines that underpin the design, development, and evaluation of therapeutic agents. This field integrates principles from biopharmaceutics, ...

The fields of pharmacology and pharmaceutical sciences converge to advance our understanding of how drugs interact with biological systems and how these agents can be engineered for optimal ...

Students from the UMass Lowell's MS in Pharmaceutical Sciences (or another relevant UMass Lowell science or engineering MS) program with a cumulative GPA of a 3.500 or greater may apply to the Ph.D.